Select a Region
North America

Browsing Archive: Oncology | EVERSANA

Posted on May 16, 20235/16/23

Shorla Oncology & EVERSANA Announce Commercial Launch of Recent FDA-Approved Nelarabine Injection for the Treatment of T-cell Leukemia Across the United States

Posted on March 23, 20233/23/23

EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis   

Posted on February 23, 20232/23/23

Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)

Posted on February 3, 20222/3/22

EVERSANA and Integra Connect Form Strategic Partnership to Advance Next Generation Oncology Commercialization Services Propelled by Real-World Evidence & Technology Platforms

Posted on August 17, 20218/17/21

Shorla Pharma Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment

EVERSANA
Posted on February 4, 20212/4/21

EC Publishes ‘Europe’s Beating Cancer Plan’ Detailing 4 Key Areas for Action

Posted on January 11, 20211/11/21

NHC Regulations on Medical Care Management Urge Accountability, Rational Drug Use, and Treatment Guide Adherence

Posted on November 30, 202011/30/20

MacroGenics and EVERSANA Announce Agreement to Support the Potential Launch and Commercialization of Margetuximab

Posted on September 2, 20209/2/20

Just Half of Germany’s Clinical Cancer Registries Fully Operational at the End of Last Year

Posted on August 25, 20208/25/20

Fiocruz Produces Breast Cancer Drug Trastuzumab for Brazil’s SUS